World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
18413
World Ranking
2905
National Ranking
1370

László Maródi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where László Maródi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 250 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

László Maródi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where László Maródi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

László Maródi is a researcher affiliated with Rockefeller University in the United States. Their research primarily spans several interconnected fields, including Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. In particular, their work delves into specialized subfields such as Immunology, Infectious Diseases, Genetics, Epidemiology, and Pulmonary and Respiratory Medicine.

The scientific contributions of László Maródi include studies focused on key topics like Immunodeficiency and Autoimmune Disorders, Blood disorders and treatments, and Respiratory viral infections research. Their research also covers Immune responses and vaccinations, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, as well as Diabetes and associated disorders.

Frequent publication venues for this researcher include:

  • Journal of Clinical Immunology
  • Frontiers in Immunology
  • The Journal of Experimental Medicine
  • Orvosi Hetilap
  • Nature

László Maródi has collaborated extensively with several coauthors, notably:

  • Jean-Laurent Casanova
  • Kristina Mironska
  • Beth A. Drolet
  • Giorgio Casari
  • Petter Brodin

Recent papers authored or coauthored by László Maródi include:

  • "Human genetic and immunological determinants of critical COVID-19 pneumonia" (2022, Nature)
  • "Studying severe long COVID to understand post-infectious disorders beyond COVID-19" (2022, Nature Medicine)
  • "Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia" (2022, The Journal of Experimental Medicine)
  • "Autoantibodies against type I IFNs in patients with critical influenza pneumonia" (2022, The Journal of Experimental Medicine)
  • "Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency" (2022, The Journal of Experimental Medicine)

Best Publications

  • Pyogenic Bacterial Infections in Humans with MyD88 Deficiency

    Horst Von Bernuth;Capucine Picard;Capucine Picard;Zhongbo Jin;Rungnapa Pankla;Rungnapa Pankla

  • Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis

    Luyan Liu;Satoshi Okada;Xiao Fei Kong;Alexandra Y. Kreins

  • Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

    Anne Puel;Anne Puel;Rainer Döffinger;Angels Natividad;Angels Natividad;Maya Chrabieh;Maya Chrabieh

  • Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome

    Kaan Boztug;Manfred Schmidt;Adrian Schwarzer;Pinaki P. Banerjee

  • Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

    Christian Jörg Braun;Kaan Boztug;Anna Paruzynski;Maximilian Witzel

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

    Julie Toubiana;Satoshi Okada;Satoshi Okada;Julia Hiller;Matias Oleastro

  • Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells

    Ludovic de Beaucoudrey;Ludovic de Beaucoudrey;Anne Puel;Anne Puel;Orchidée Filipe-Santos;Orchidée Filipe-Santos;Aurélie Cobat;Aurélie Cobat

  • A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    Nicolino Ruperto;Daniel J. Lovell;Ruben Cuttica;Nick Wilkinson

  • Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency

    Capucine Picard;Capucine Picard;Horst Von Bernuth;Horst Von Bernuth;Horst Von Bernuth;Pegah Ghandil;Pegah Ghandil;Pegah Ghandil;Maya Chrabieh;Maya Chrabieh

  • Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity

    Cheng Lung Ku;Horst Von Bernuth;Horst Von Bernuth;Capucine Picard;Shen Ying Zhang

  • The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88

    Bing He;Raul Santamaria;Weifeng Xu;Montserrat Cols

  • Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis

    Anne Puel;Sophie Cypowyj;László Maródi;Laurent Abel

  • Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome

    Cristina Woellner;E. Michael Gertz;Alejandro A. Schäffer;Macarena Lagos

  • Human TLR-7-, -8-, and -9-Mediated Induction of IFN-α/β and -λ Is IRAK-4 Dependent and Redundant for Protective Immunity to Viruses

    Kun Yang;Kun Yang;Anne Puel;Shenying Zhang;Shenying Zhang;Céline Eidenschenk

  • DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients

    Susanne E. Aydin;Sara Sebnem Kilic;Caner Aytekin;Ashish Kumar

  • Innate cellular immune responses in newborns

    László Maródi

  • Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages.

    L Maródi;H M Korchak;R B Johnston

  • Hematologically important mutations: X-linked chronic granulomatous disease (third update).

    Dirk Roos;Douglas B. Kuhns;Anne Maddalena;Joachim Roesler

  • Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors.

    L Maródi;S Schreiber;D C Anderson;R P MacDermott

Frequent Co-Authors

Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Capucine Picard
Capucine Picard Université Paris Cité
Laurent Abel
Laurent Abel Université Paris Cité
Alain Fischer
Alain Fischer Collège de France
Waleed Al-Herz
Waleed Al-Herz Kuwait University
Christoph Wanner
Christoph Wanner University of Würzburg
Helen Chapel
Helen Chapel University of Oxford
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Ozden Sanal
Ozden Sanal Hacettepe University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students transition into fields like nursing to gain practical medical experience, which complements immunological knowledge. Programs such as accelerated FNP programs offer a fast track to becoming a Family Nurse Practitioner, allowing graduates to work closely with patients and integrate immunology concepts in clinical settings.

For individuals without a nursing background, online ABSN programs for non nurses provide a pathway to earn a Bachelor of Science in Nursing quickly and conveniently. These programs build foundational knowledge and practical skills essential for healthcare roles that often collaborate with immunologists.

If admission competitiveness is a concern, exploring the easiest ABSN program to get into can be a strategic move. These programs typically have more accessible enrollment criteria without compromising quality education.

Additionally, a Licensed Practical Nurse credential is a respected entry point into healthcare. For a smooth application process, consider LPN programs with easiest admission requirements. Earning an LPN enables hands-on patient care experience, which pairs well with immunology expertise in various medical environments.

Best Scientists Citing László Maródi

Trending Scientists

Recently Published Articles